Study To Assess Changes In The Number Of Nerves In The Skin At The Site Where Where Tanezumab Is Injected

NCT01030640 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis Pain
Chronic Low Back Pain
Pain Due to Interstitial Cystitis

Interventions

OTHER: placebo
BIOLOGICAL: tanezumab

Sponsor

Pfizer